Medical/Pharmaceuticals
4G Clinical Announces Appointment of Life Science Service and Tech Leader Dr. Ronan Brown as New Chief Operating Officer
Brown brings years of industry expertise to oversee and maximize 4G Clinical's operational efficiency and excellence. WELLESLEY, Mass., Aug. 16, 2024 /PRNewswire/ -- 4G Clinical, a global leader in randomization and trial supply management (RTSM) and supply forecasting optimization software for ...
Vimgreen Completes Enrollment of Its Phase 2 Clinical Trial Evaluating VG081821AC for the Treatment of Parkinson's Disease
HANGZHOU, China, Aug. 15, 2024 /PRNewswire/ -- Vimgreen Pharmaceuticals, a science-driven pharmaceutical company focused on the modulation of adenosine signaling, announced today the completion of enrollment of its Phase 2 clinical trial of VG081821AC, a novel adenosine A2A receptor (A2AR) antago...
Cresilon Receives FDA Clearance for TRAUMAGEL
Hemostatic gel designed to control moderate to severe bleeding in seconds and save lives NEW YORK, Aug. 15, 2024 /PRNewswire/ -- Cresilon Inc. ("Cresilon"), a Brooklyn -based biotechnology company focused on hemostatic medical device technologies, today announced it has received U.S. Food and Dru...
LakeShore Biopharma Announces Financial Results for Fiscal Year 2024
Gross margin increased to 79.5%; product pipeline continues to advance Company anticipates double-digit year-over-year revenue growth and bottom line breakeven for Fiscal Year 2025 GAITHERSBURG, Md., Aug. 15, 2024 /PRNewswire/ -- LakeShore Biopharma Co., Ltd. (Nasdaq: LSB) ("LakeShore Biopharma"...
Fractal Launches vaidya.ai, a Multimodal Health Assistant
NEW YORK, Aug. 15, 2024 /PRNewswire/ -- Fractal (www.fractal.ai
AI + medical care|Neusoft Education launches the Healthcare Training Lab to support practical teaching for software-related majors in universities
HONG KONG, Aug. 15, 2024 /PRNewswire/ -- With the trend of population aging in China, the government and all sectors of society are taking active measures to address the challenges of the digital age. Following the rise of the "silver economy", the smart elderly care industry will be promising, a...
NANOFORM COLLABORATES WITH TAKEDA ON THEIR PLASMA-DERIVED THERAPY DEVELOPMENT
HELSINKI, Aug. 15, 2024 /PRNewswire/ -- Nanoform Finland Plc ("Nanoform"), the medicine performance-enhancing company, today announced that it is to enter into a pre-clinical development agreement with the Plasma-derived Therapies Business Unit of Takeda Pharmaceuticals, Inc., the R&D-driven biop...
NSG BioLabs and Merck Collaborates to Support Biotech Start-ups to Advance Research & Innovations
* The collaboration focuses on offering guidance, mentorship, and access to
expertise to the start-ups housed within NSG Biolabs SINGAPORE, Aug. 15, 2024
/PRNewswire/ --NSG BioLabs
Sisram Medical to Report H1 2024 Financial Results on August 21 and Hold a Conference Call on August 22
H1 2024 conference call to be held on August 22, at 8:30 a.m. Eastern Time HONG KONG, Aug. 15, 2024 /PRNewswire/ -- Sisram Medical Ltd (the "Company" or "Sisram", stock code: 1696.HK; together with its subsidiaries referred as the " Group"), a global consumer wellness group featuring a first-of-it...
Ivonescimab (PD-1/VEGF) Received Priority Review from China's NMPA for First-Line Treatment of PD-L1 Positive NSCLC
The Second Indication of Ivonescimab in NSCLC 2L+ EGFRm NSCLC Already Approved in May 2024 HONG KONG, Aug. 14, 2024 /PRNewswire/ -- Akeso, Inc. (HKEX: 9926.HK) ("Akeso,") today announced that the National Center for Drug Evaluation of the State Drug Administration ofthe People's Republic of China...
REMOVERY TO PROVIDE 150 FREE TATTOO REMOVAL PACKAGES TO COMMEMORATE THE INAUGURAL WORLD TATTOO REMOVAL DAY
On August 14, the world's tattoo removal experts will provide 150 treatments to individuals in need across their global studio locations AUSTIN, Texas, Aug. 14, 2024 /PRNewswire/ -- To bring awareness to the safety, efficacy and accessibility of tattoo removal treatment,Removery is presenting th...
Strategic Partnership Between Beyond Medical Group (Singapore) and SingMed Medical Centre (Cambodia) Enhances Healthcare Collaboration
Beyond Medical Pledges to Join Forces with SingMed to Enhance Access to
Healthcare and Elevate Care Standards Across Both Regions
SINGAPORE, Aug. 14, 2024 /PRNewswire/ -- Beyond Medical Group Singapore
Alfred Health Enhances Cancer Patient Care with Oracle Health
Leading Victorian healthcare network integrates oncology and EHR solutions to deliver more informed care across its locations AUSTIN, Texas and VICTORIA, Australia, Aug. 13, 2024 /PRNewswire/ -- Leading Victorian healthcare network, Alfred Health, has extended its long-standing Oracle Health foo...
Qilian International Holding Group Ltd. Announces Trading Ticker Symbol to "BGM"
CHENGDU, China, Aug. 13, 2024 /PRNewswire/ -- Qilian International Holding Group Ltd. ("Qilian" or the "Company") (NASDAQ: QLI), aChina-based pharmaceutical and chemical products manufacturer, announced today that effective onAugust 11, 2024, its Class A ordinary shares will begin trading on the...
Sinch AI Used to Safely Pre-Triage Patients
STOCKHOLM, Aug. 13, 2024 /PRNewswire/ -- Sinch (Sinch AB (publ) – XSTO: SINCH), which is pioneering the way the world communicates through its Customer Communications Cloud, is excited to announce that MINDD, a Dutch medical technology company, has selected Sinch to develop an advanced AI-driven...
Australian biotech incubator Proto Axiom announces $20M Series B first close
$20M unlocked for opportunities in Australian biotech innovation, valuing Proto Axiom at$90M SYDNEY, Aug. 13, 2024 /PRNewswire/ -- Proto Axiom, the Australian biomedical technology incubator has today announced a$20 million first close of its targeted$30 million Series B, to bolster Australia's...
Docquity Drives Demand for SIT Pharma's Duo Probiotics in Thailand, Achieving 31% Sales Growth in 6 months
* Docquity's Awareness to Advocacy (A2A) Program and strong local distribution network enabled SIT's duo probiotic sales to surpass the market growth rate of 15% * The technology platform boosted SIT's HCP education efforts, more than doubling its reach to 2,000 HCPs within six months and aim...
Registrational Phase III Study of Lisaftoclax in Newly-Diagnosed Patients with Higher-Risk Myelodysplastic Syndrome Cleared by China CDE
ROCKVILLE, Md. and SUZHOU, China, Aug. 13, 2024 /PRNewswire/ -- Ascentage Pharma (6855.HK), a global, integrated biopharmaceutical company engaged in discovering, developing and commercializing both first- and best-in-class therapies for malignancies, announced today it has been cleared by the Ce...
Chang Gung Cancer Proton Therapy Achieves Breakthrough
Research Confirms Effective Control of Large Liver Cancer, Doubling Survival
Time
Published in the International Journal of Radiation Oncology
Biosyngen's BRG01 Receives FDA Approval for Phase II Clinical Trial
SINGAPORE, Aug. 13, 2024 /PRNewswire/ -- Biosyngen is proud to announce that the U.S. Food and Drug Administration (FDA) has approved its BRG01, an EBV-specific CAR-T cell therapy, to proceed with a pivotal Phase lI clinical trial.This marks the first cell therapy to enter Phase lI trials in both...
Week's Top Stories
Most Reposted
Rocket Travel by Agoda Shares Revealing New Report and Showcases Solution to Transform Hotel Distribution
[Picked up by 313 media titles]
2024-11-21 10:30Rockwell Automation and Microsoft Deliver on a Shared Vision to Accelerate Industrial Transformation
[Picked up by 308 media titles]
2024-11-20 13:29Durabook and Parent Company, Twinhead International Corp., Celebrate 40 Years of Innovation in Computing Solutions
[Picked up by 301 media titles]
2024-11-20 16:30Travel loyalty programs to focus on offering personalized and flexible customer experiences in 2025
[Picked up by 298 media titles]
2024-11-19 10:42Philips and Edith Cowan University Australia Collaborate to Equip the Next Generation of Healthcare Professionals to leverage new technologies
[Picked up by 284 media titles]
2024-11-20 09:00